Ep. 76: Neurological side effects and drug interactions of new antiviral drugs against SARS-CoV-2

$Ep. 71: Neurological complications from cancer immunotherapy: Moderator: Antonio Malvaso Guest: Stefania Cuzzubbo Dr. Antonio Malva hosts Dr. Stefania Cuzzubbo to discuss neurological complications from cancer immunotherapy. Dr. Cuzzubbo highlights immune-related adverse events, focusing on peripheral nervous system issues. The importance of early diagnosis using MRI, lumbar puncture, and nerve studies is emphasized. Treatment involves promptly stopping the drug and using steroids, with alternative therapies explored for steroid-refractory cases. Continued research in this evolving field is crucial.$

Ep. 70: Paraneoplastic neurological syndromes: diagnosis and treatment: Moderator: Antonio Malvaso (Pavia, Italy) Guest: Alberto Vogrig (Udine, Italy) In this episode of EAN Cast Weekly Neurology, Dr. Antonio Malvaso, a neurology resident, welcomes Dr. Alberto Vogrig, an international expert in the field of paraneoplastic neurological syndromes. They discuss the definition of these syndromes, emphasizing the causal relationship with cancer and their immune-mediated pathogenesis. They also talk about the revised diagnostic criteria and the importance of clinical diagnosis, laboratory techniques, and oncologic screening. The treatment for these syndromes includes immunosuppression, cancer therapy, and symptomatic treatment, tailored to the specific symptoms. by eanCast: Weekly Neurology

18 min listen

Ep. 69: Overview on differential diagnosis: Moderator: Alberto Vogrig (Udine, Italy) Guest: Giulia Berzero (Milan, Italy) In this episode Dr. Alberto Vogrig is joined by Dr. Giulia Berzero to discuss the clinical approach to neurological symptoms in patients with cancer. She highlights the increasing occurrence of neurological complications in cancer patients due to improved survival rates and novel cancer treatments. Dr. Berzero emphasizes the importance of considering patient-related factors, tumor-related factors, and treatment modalities in assessing the risk of developing neurological symptoms. She also explains the signs that may prompt suspicion of brain metastasis and provides guidance on assessing and diagnosing CNS dissemination in cancer patients. Dr. Berzero stresses the need for a multidisciplinary approach and collaboration with oncologists to optimize patient care. by eanCast: Weekly Neurology

15 min listen

Ep. 68: Analysis of CIDP guidelines: Moderator: Panagiotis Zis (Nicosia, Cyprus) Guest: Peter Van den Bergh (Brussels, Belgium) In this episode of the EAN Cast, Prof. Zis is joined by Prof. Van den Bergh to discuss the recently updated guidelines for diagnosing and treating Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). The existing guidelines were last revised over a decade ago, and this new version aims to reflect the latest advancements in clinical and basic research. Prof. Van den Bergh highlights the common pitfalls in CIDP diagnosis and emphasizes the need for accurate diagnostic criteria. The guidelines include flowcharts, tables, and criteria for different CIDP variants, as well as suggestions for supportive criteria to upgrade the diagnosis from possible CIDP to CIDP. The episode also delves into the treatment approaches, with an emphasis on corticosteroids, IVIG, and plasma exchange, and when to consider nerve biopsy. by eanCast: Weekly Neurology

22 min listen

Ep. 67: EAN and WFN Brain Health Initiatives: Moderator: Thomas Berger (Vienna, Austria) Guest: Wolfgang Grisold (Vienna, Austria) In this podcast episode of EAN Cast, Professor Thomas Berger, Chair of the Department of Neurology at the Medical University in Vienna, and Professor Wolfgang Grisold, the current president of the World Federation of Neurology, discuss two important topics. First, they delve into the history and implementation of the World Health Organization's (WHO) Intersectoral Global Action Plan for epilepsy and other neurological disorders (ICAP). They emphasize that ICAP is a global effort to improve neurological services, and while epilepsy is a key focus, it covers various neurological disorders across countries, regardless of their income level. They highlight the importance of ICAP's five points: policy, treatment, prevention, research and innovation, and public health. Secondly, they discuss the concept of brain health, a mission closely related to ICAP, and it by eanCast: Weekly Neurology

23 min listen

Discover this podcast and so much more

Ep. 76: Neurological side effects and drug interactions of new antiviral drugs against SARS-CoV-2

Ep. 76: Neurological side effects and drug interactions of new antiviral drugs against SARS-CoV-2

Description

Titles in the series (97)

More Episodes from eanCast: Weekly Neurology

Related podcast episodes